Endologix, Inc. (NASDAQ:ELGX)

CAPS Rating: 2 out of 5

The Company develops, manufactures, sells and markets minimally invasive therapies for the treatment of cardiovascular disease.

ELGX News and Commentary

Caps

How do you think ELGX will perform against the market?

Add Stock to CAPS Watchlist

All Players

63 Outperform
13 Underperform
 

All-Star Players

13 Outperform
5 Underperform
 

Wall Street

10 Outperform
0 Underperform
 

Top ELGX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

smoothbore09 (< 20)
Submitted September 06, 2008

Endologix is releasing two important new products in the late fall of 2008 and early 2009. Both are PMA supplements, so FDA approval is pretty much in the bag. The first is a new 34MM cuff size that comprises about 15-20% of the AAA market (which is… More

dustbusterz (< 20)
Submitted November 10, 2007

they may have a great produst or service to offer, but i fail to see any profitability thus far.

ELGX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about ELGX.

Recs

0
Member Avatar whatevmatil (< 20) Submitted: 3/23/2012 12:24:02 PM : Outperform Start Price: $14.30 ELGX Score: -151.55

Once/if Nellix and Ventana get approved, this stock should fly.

I hesitate to rate this in caps due to volitility, but whatever, I think it will go up ultimately.

Recs

0
Member Avatar mgebremichael (< 20) Submitted: 3/7/2012 10:52:00 AM : Outperform Start Price: $12.48 ELGX Score: -151.77

Small company with strong growth potential. Company develops and sales devices to help with aortic disorders.

Recs

0
Member Avatar lola99999 (< 20) Submitted: 12/16/2009 9:55:51 PM : Outperform Start Price: $4.80 ELGX Score: -122.41

ELGX

Leaderboard

Find the members with the highest scoring picks in ELGX.

Score Leader

JavaWithMe

JavaWithMe (35.61) Score: +375.45

The Score Leader is the player with the highest score across all their picks in ELGX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
retailsails 97.85 8/15/2012 Underperform 1Y $13.11 -56.60% +89.69% +146.29 0 Comment
CarlosDK 20.60 1/28/2013 Underperform 5Y $15.77 -63.92% +77.90% +141.82 0 Comment
TarpWatchdog 99.68 12/14/2009 Underperform 5Y $4.45 +27.87% +138.47% +110.61 0 Comment
Cannabis911 99.75 12/11/2009 Underperform 5Y $4.38 +29.91% +140.10% +110.20 0 Comment
Snarfist 42.53 2/23/2010 Underperform 3M $3.44 +65.41% +142.57% +77.17 0 Comment
up4anything < 20 3/18/2010 Underperform 1Y $3.64 +56.32% +127.82% +71.50 0 Comment
zackstracker1 45.53 3/3/2016 Underperform NS $8.82 -35.49% +34.26% +69.75 0 Comment
pattym318 96.56 1/5/2007 Underperform 1Y $3.30 +72.42% +101.78% +29.35 0 Comment
chushogi 71.63 12/29/2016 Underperform 5Y $5.62 +1.25% +18.84% +17.60 0 Comment
Under5 < 20 11/14/2017 Outperform 5Y $4.75 +19.79% +3.64% +16.15 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
trackbtigresearc 49.86 8/25/2014 Outperform NS $13.31 -57.25% +33.30% -90.55 0 Comment
TrackCreditSuiss 90.58 6/30/2014 Outperform NS $15.18 -62.52% +36.32% -98.84 0 Comment
TrackBMOCapital < 20 9/7/2012 Outperform NS $12.37 -54.00% +85.25% -139.25 0 Comment
TrackPiperJaff 85.03 8/9/2012 Outperform NS $13.00 -56.23% +90.16% -146.39 0 Comment
TrackRWBaird 88.47 1/14/2011 Outperform NS $7.09 -19.75% +108.11% -127.86 0 Comment
TrackOppenheimer 47.30 12/15/2010 Outperform NS $6.55 -13.13% +114.38% -127.51 0 Comment
TrackWedbush 87.11 12/10/2010 Outperform NS $5.78 -1.56% +114.90% -116.46 0 Comment
TrackLazardCapit 78.46 7/2/2009 Outperform NS $3.48 +63.51% +196.46% -132.96 0 Comment
TrackDawsonJames < 20 5/23/2007 Outperform NS $4.39 +29.61% +84.40% -54.79 0 Comment
TrackSunTrustRH 88.07 4/5/2007 Outperform NS $3.94 +44.42% +96.30% -51.89 0 Comment

Featured Broker Partners